SYNCROSOME

Discover the latest news from Etap-LAB

Contact an expert

Published on the 26 January 2017

Syncrosome: poster Preclinical PAH Sugen – European Respiratory Society meeting

Pulmonary arterial hypertension (PAH) is a rare cardiopulmonary disorder characterized by progressive obliteration of small pulmonary arterioles that leads to increased pulmonary vascular resistance. …

Science and innovation Events
Published on the 12 December 2016

Mouse ischemia reperfusion: a good preclinical model for myocardial infarction?

Myocardial infarction (MI) results from a biphasic ischemia/reperfusion (I/R) injury to the heart. The disease is linked to cardiomyocyte apoptosis and further along to inflammation-based tissue damag…

Science and innovation
Published on the 9 December 2016

SYNCROSOME CIR accreditation

For more than 6 years now, Syncrosome has worked as a preclinical CRO accredited by the French Ministry of Higher Education and Research for Research Tax Credits (CIR). Our recognition procur…

Company
Published on the 23 November 2016

Syncrosome sets up a new preclinical PAH (Pulmonary Arterial Hypertension) model in mouse.

Pulmonary arterial hypertension (PAH) is a syndrome in which pulmonary arterial obstruction increases pulmonary vascular resistance, leading to right ventricular hypertrophy (RVH), failure, and death….

Science and innovation
Published on the 15 November 2016

Syncrosome keeps increasing its In vivo Preclinical skills

In the framework of our development, we are proud to announce the recruitment of our new scientific colleague, Guénaelle CANET. She will work in our Technical Department at the Lab and will …

Science and innovation
Published on the 3 November 2016

Join Syncrosome team at Bio-Europe in Cologne, Germany, next week!

Syncrosome invites you to visit us at Bio-Europe, November 7th to November 9th 2016, in Cologne, Germany. Emmanuelle Bettendorf, our Business Developer would be delighted to meet you their and discus…

Events
Published on the 18 October 2016

Syncrosome at the 2nd DDIP in Munich

The 2nd Drug Discovery Innovation Programme will feature 2 days of interactive presentations, poster presentation and networking opportunity, in Hamburg (Germany) from 20 to 21st of October. This conf…

Science and innovation Events
Published on the 5 September 2016

Syncrosome & the 2nd Annual Neuroscience Conference.

As you know Syncrosome is a preclinical CRO managing efficacy in vivo/ in vitro studies with more than 15 disease models validated in house and reproducible. Syncrosome is involved in Central Nervous…

Events

Discover our scientific resources and browse posters…

Discover our resources